Christopher F. Cain

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy”.

Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0127

N/A

0DataRank · unranked

14 citations

Qin Xu, Walker T. Spalek, Christopher F. Cain, Chang Won Kang, Chih-Hang Anthony Tang +3 more

Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues

ChemMedChem(2023)10.1002/cmdc.202300474

N/A

0DataRank · unranked

4 citations

Christopher F. Cain, Michael J. Garza, David Degen, Richard H. Ebright, Juan R. Del Valle +1 more